Timeline

Richard Delorme
Permanent Researcher
06 Feb 2019
publication

Morning Plasma Melatonin Differences in Autism: Beyond the Impact of Pineal Gland Volume

Read more
14 Jan 2019
publication

Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations

Read more
09 Jan 2019
publication

Synesthesia & Autistic Features in a Large Family:evidence for spatial imagery as a common factor

Read more
27 Feb 2018
project

EU-AIMS

Read more
18 Dec 2017
publication

Heritability of the melatonin synthesis variability in autism spectrum disorders

Read more
23 Oct 2017
publication

A framework to identify contributing genes in patients with Phelan-McDermid syndrome

Read more
21 Nov 2016
project

Communauté des médecins affiliés de l’Institut Pasteur

Read more
14 Nov 2016
software

GRAVITY

Read more
05 Nov 2016
project

SoNeTAA

Read more
10 May 2016
publication

CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders

Read more
22 Feb 2016
project

Phelan McDermid Syndrome: from mechanisms to treatments

Read more
23 Sep 2015
publication

A de novo microdeletion of SEMA5A in a boy with autism spectrum disorder and intellectual disability

Read more
03 Sep 2015
publication

11q24.2-25 micro-rearrangements in autism spectrum disorders: Relation to brain structures

Read more
16 Jul 2015
project

Establishment of cohorts of patients with ASD

Read more
01 Dec 2014
team

Human Genetics and Cognitive Functions

Read more
04 Sep 2014
publication

Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments

Read more
10 Jul 2014
publication

Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission

Read more
24 Apr 2014
publication

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

Read more
03 Mar 2014
publication

Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders

Read more
03 Dec 2013
publication

Heterozygous FA2H mutations in autism spectrum disorders

Read more
07 Oct 2013
publication

The emerging role of SHANK genes in neuropsychiatric disorders

Read more
06 Jun 2013
publication

Progress toward treatments for synaptic defects in autism

Read more
27 Jun 2012
publication

High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters

Read more
09 Feb 2012
publication

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders

Read more
26 May 2011
publication

Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders

Read more
04 Mar 2011
publication

Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations

Read more
20 Jan 2011
publication

Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability

Read more
15 Jul 2010
publication

Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population

Read more
06 Jul 2010
publication

Key role for gene dosage and synaptic homeostasis in autism spectrum disorders

Read more
05 Jul 2010
publication

Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls

Read more
01 Feb 2009
publication

[Autism: more evidence of a genetic cause]

Read more
23 Jan 2009
publication

An investigation of ribosomal protein L10 gene in autism spectrum disorders

Read more
01 Sep 2008
publication

Analysis of X chromosome inactivation in autism spectrum disorders

Read more
17 Dec 2006
publication

Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders

Read more
01 Jan 2006
publication

Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders

Read more